Identification | Back Directory | [Name]
Heptanoic acid, 2-[[4-(methylamino)benzoyl]amino]-7-[[(phenylmethoxy)carbonyl]amino]-, (2S)- | [CAS]
1186629-63-9 | [Synonyms]
BSBM6 BSBM-6 BSBM 6 Heptanoic acid, 2-[[4-(methylamino)benzoyl]amino]-7-[[(phenylmethoxy)carbonyl]amino]-, (2S)- | [Molecular Formula]
C23H29N3O5 | [MOL File]
1186629-63-9.mol | [Molecular Weight]
427.49 |
Hazard Information | Back Directory | [Description]
BSBM6 is an inhibitor of Aβ aggregation and neuronal toxicity. It acts by reversing the aggregation and toxicity of amyloid-β (Aβ) peptides. | [Uses]
BSBM6 is a compound with the activity of inhibiting Aβ aggregation and regulating Aβ aggregation. BSBM6 can be demonstrated to inhibit Aβ aggregation through molecular dynamics simulation and related experiments, reducing soluble oligomers, and providing structural guidance for the design of new aggregation regulating ligands. | [References]
[1] New mimetic peptides inhibitors of Αβ aggregation. Molecular guidance for rational drug design DOI:10.1016/j.ejmech.2015.03.042 |
|
|